Effects of Human Adipose-Derived Stem Cells in Regenerating the Damaged Renal Tubular Epithelial Cells in an Animal Model of Cisplatin-Induced Acute Kidney Injury
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: We conducted this experimental study to examine whether human adipose-derived stem cells (ADSCs) are effective in achieving a recovery of damaged renal tubular epithelial cells in an animal model of cisplatin-induced acute kidney injury using rats. Methods: To examine the in vitro effects of ADSCs in improving nephrotoxicity, we treated mouse renal tubular epithelial cells with both ADSCs and cisplatin mouse renal tubular epithelial cells. And we equally divided 30 male white Sprague-Dawley (SD) rats into the three groups: the control group (intraperitoneal injection of a sterile saline), the cisplatin group (intraperitoneal injection of cisplatin) and the ADSC group (intraperitoneal injection of cisplatin and the hADSC via the caudal vein). At five days after the treatment with cisplatin, serum levels of blood urine nitrogen (BUN) and creatinine were measured from each SD rat. We performed histopathologic examinations of tissue samples obtained from the kidney. Results: The degree of the expression of TNF-α and that of Bcl-2 were significantly higher and lower respectively, in cisplatin group (P<0.05). Serum levels of BUN (P=0.027) and creatinine (P=0.02) were significantly higher in cisplatin group. On histopathologic examinations, there was a significant difference in the ratio of the renal injury between cisplatin group and ADSC group (P=0.002). Conclusion: The ADSCs might have a beneficial effect in regenerating the damaged renal tubular epithelial cells.
Abstract
Background: We conducted this experimental study to examine whether human adipose-derived stem cells (ADSCs) are effective in achieving a recovery of damaged renal tubular epithelial cells in an animal model of cisplatin-induced acute kidney injury using rats. Methods: To examine the in vitro effects of ADSCs in improving nephrotoxicity, we treated mouse renal tubular epithelial cells with both ADSCs and cisplatin mouse renal tubular epithelial cells. And we equally divided 30 male white Sprague-Dawley (SD) rats into the three groups: the control group (intraperitoneal injection of a sterile saline), the cisplatin group (intraperitoneal injection of cisplatin) and the ADSC group (intraperitoneal injection of cisplatin and the hADSC via the caudal vein). At five days after the treatment with cisplatin, serum levels of blood urine nitrogen (BUN) and creatinine were measured from each SD rat. We performed histopathologic examinations of tissue samples obtained from the kidney. Results: The degree of the expression of TNF-α and that of Bcl-2 were significantly higher and lower respectively, in cisplatin group (P<0.05). Serum levels of BUN (P=0.027) and creatinine (P=0.02) were significantly higher in cisplatin group. On histopathologic examinations, there was a significant difference in the ratio of the renal injury between cisplatin group and ADSC group (P=0.002). Conclusion: The ADSCs might have a beneficial effect in regenerating the damaged renal tubular epithelial cells.
참고문헌 (24)
- Schrier RW, "Acute renal failure: definitions, diagnosis, pathogenesis, and therapy", J Clin Invest, 114, pp.5~14 (2004)
- Nishida M, "Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice", Biochem Biophys Res Commun, 324, pp.341~347 (2004)
- Joannidis M, "Clinical review : timing of renal replacement therapy", Crit Care, 15, pp.223~ (2011)
- Garcovich M, "Clinical use of albumin in hepatology", Blood Transfus, 7, pp.268~277 (2009)
- Cadwallader AB, "The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis", Br J Pharmacol, 161, pp.1~16 (2010)
- Needham E, "Management of acute renal failure", Am Fam Physician, 72, pp.1739~1746 (2005)
- Morigi M, "Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure", J Am Soc Nephrol, 15, pp.1794~1804 (2004)
- Cimino GD, "Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer", Bioanalysis, 5, pp.369~391 (2013)
- Shen DW, "Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes", Pharmacol Rev, 64, pp.706~721 (2012)
- Di Nicola M, "Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli", Blood, 99, pp.3838~3843 (2002)
- Lin F, "Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice", J Am Soc Nephrol, 14, pp.1188~1199 (2003)
- Chhabra P, "The use of stem cells in kidney disease", Curr Opin Organ Transplant, 14, pp.72~78 (2009)
- Gimble J, "Adipose-derived adult stem cells: isolation, characterization, and differentiation potential", Cytotherapy, 5, pp.362~369 (2003)
- Zuk PA, "Human adipose tissue is a source of multipotent stem cells", Mol Biol Cell, 13, pp.4279~4295 (2002)
- Bunnell BA, "Adipose-derived stem cells: isolation, expansion and differentiation", Methods, 45, pp.115~120 (2008)
- Bi B, "Stromal cells protect against acute tubular injury via an endocrine effect", J Am Soc Nephrol, 18, pp.2486~2496 (2007)
- Ysebaert DK, "Identification and kinetics of leukocytes after severe ischemia", reperfusion renal injury, 2000, pp.15, 1562~1574
- Basile DP, "Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function", Am J Physiol Renal Physiol, 281, pp.F887~F899 (2001)
- Rossert J, "Drug-induced acute interstitial nephritis", Kidney Int, 60, pp.804~817 (2001)
- Greene SN, "Effects of cyclooxygenase inhibitor treatment on the renal toxicity of cisplatin in rats", Cancer Chemother Pharmacol, 65, pp.549~556 (2010)
- Suddek GM, "Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals", Cancer Chemother Pharmacol, 67, pp.1035~1044 (2011)
- Humphreys BD, "Mesenchymal stem cells in acute kidney injury", Annu Rev Med, 59, pp.311~325 (2008)
- Thomas J, "Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor", Curr Opin Hematol, 9, pp.183~189 (2002)
- Caplan AI, "Mesenchymal stem cells as trophic mediators", J Cell Biochem, 98, pp.1076~1084 (2006)